union carbide tamex tobacco sucker control agent
bayer cropscience pty ltd - butralin | decanol | octan-1-ol | dimethyl formamide - plant regulator - tobacco - tobacco sucker
tamex tobacco sucker control agent
syngenta crop protection pty limited - butralin | decanol | octan-1-ol - plant regulator - tobacco - prevent sucker development | sucker control | control of suckers
agchem tamex tobacco sucker control agent
crop care australasia pty ltd - butralin | decanol | octan-1-ol - plant regulator - tobacco - prevent sucker development
butralin
nufarm australia limited - butralin - unknown - butralin anilide/aniline-dinitro active 0.0 - active constituent
nufarm tobago tobacco sucker control agent
nufarm australia limited - butralin - plant regulator - tobacco - prevent sucker development
tobago tobacco sucker control agent
nufarm australia limited - butralin - plant regulator - tobacco - prevent sucker development
terbutaline sulfate tablet
rebel distributors corp - terbutaline sulfate (unii: 576pu70y8e) (terbutaline - unii:n8onu3l3pg) - terbutaline sulfate 2.5 mg - terbutaline sulfate is indicated for the prevention and reversal of bronchospasm in patients 12 years of age and older with asthma and reversible bronchospasm associated with bronchitis and emphysema. terbutaline sulfate is contraindicated in patients known to be hypersensitive to sympathomimetic amines or any component of this drug product.
terbutaline sulfate injection
hikma pharmaceuticals usa inc. - terbutaline sulfate (unii: 576pu70y8e) (terbutaline - unii:n8onu3l3pg) - terbutaline sulfate 1 mg in 1 ml - terbutaline sulfate injection, usp is indicated for the prevention and reversal of bronchospasm in patients 12 years of age and older with asthma and reversible bronchospasm associated with bronchitis and emphysema. 1. prolonged tocolysis terbutaline sulfate has not been approved and should not be used for prolonged tocolysis (beyond 48-72 hours). in particular, terbutaline sulfate should not be used for maintenance tocolysis in the outpatient or home setting (see boxed warning: prolonged tocolysis ). 2. hypersensitivity terbutaline sulfate injection is contraindicated in patients known to be hypersensitive to sympathomimetic amines or any component of this drug product.
terbutaline sulfate- terbutaline sulfate tablet
pd-rx pharmaceuticals, inc. - terbutaline sulfate (unii: 576pu70y8e) (terbutaline - unii:n8onu3l3pg) - terbutaline sulfate 5 mg - terbutaline sulfate is indicated for the prevention and reversal of bronchospasm in patients 12 years of age and older with asthma and reversible bronchospasm associated with bronchitis and emphysema. 1. tocolysis oral terbutaline sulfate has not been approved and should not be used for acute or maintenance tocolysis. [see boxed warning: tocolysis . ] 2. hypersensitivity terbutaline sulfate is contraindicated in patients known to be hypersensitive to sympathomimetic amines or any component of this drug product.
terbutaline sulfate- terbutaline sulfate injection, solution
athenex pharmaceutical division, llc. - terbutaline sulfate (unii: 576pu70y8e) (terbutaline - unii:n8onu3l3pg) - terbutaline sulfate 1 mg in 1 ml - terbutaline sulfate injection is indicated for the prevention and reversal of bronchospasm in patients 12 years of age and older with asthma and reversible bronchospasm associated with bronchitis and emphysema. - prolonged tocolysis terbutaline sulfate has not been approved for and should not be used for prolonged tocolysis (beyond 48 to 72 hours). in particular, terbutaline sulfate should not be used for maintenance tocolysis in the outpatient or home setting [see boxed warning, prolonged tocolysis ]. - hypersensitivity terbutaline sulfate injection is contraindicated in patients known to be hypersensitive to sympathomimetic amines or any component of this drug product.